共 38 条
- [1] INCREASING RATES OF HBsAg CLEARANCE AND SEROCONVERSION IN PATIENTS WITH HBeAg-NEGATIVE DISEASE TREATED WITH PEGINTERFERON ALFA-2A ± LAMIVUDINE: RESULTS OF 5-YEAR POST-TREATMENT FOLLOW UPJOURNAL OF HEPATOLOGY, 2009, 50 : S336 - S336Marcellin, P.Piratvisuth, T.Brunetto, M.Bonino, F.Lau, G. K. K.Farci, P.Yurdaydin, C.Gurel, S.Wu, J.Popescu, M.
- [2] IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B HBSAG SERUM LEVELS EARLY DURING TREATMENT WITH PEGINTERFERON ALFA-2A PREDICT HBSAG CLEARANCE 4 YEARS POST-TREATMENTHEPATOLOGY, 2008, 48 (04) : 718A - 719AMarcellin, PatrickBrunetto, MauriziaBonino, FerruccioHadziyannis, Stephanos J.Kapprell, Hans-PeterMcCloud, Philip I.Batrla, Richard
- [3] KINETICS OF HBSAG DECLINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B TREATED WITH PEGINTERFERON ALFA-2A ACCORDING TO GENOTYPE AND ITS ASSOCIATION WITH SUSTAINED HBSAG CLEARANCE 4 YEARS POST-TREATMENTHEPATOLOGY, 2008, 48 (04) : 740A - 740ABrunetto, MouriziaBonino, FerruccioMarcellin, PatrickButton, PeterBatrla, Richard
- [4] HBSAG CLEARANCE CONTINUES TO INCREASE POST-TREATMENT IN PATIENTS WITH HCV/HBV COINFECTION TREATED WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRIN: 1.5 YEAR FOLLOW-UPHEPATOLOGY, 2009, 50 (04) : 503A - 504ALiu, Chun-JenChuang, Wan-LongLee, Chuan-MoYu, Ming-LungLu, Sheng-NanDai, Chia-YenHuang, Jee-FuHu, Tsung-HuiChen, Chien-HungHung, Chao-HungWang, J. H.Wu, Shun-ShengLiao, L. Y.Kuo, H. T.Chao, You-ChenTung, S. Y.Yang, Sien-SingSu, W. W.Lin, Chih-LinKao, Jia-HorngLiu, Chen-HuaChen, Pei-JerChen, Ding-Shinn
- [5] SERUM HBSAG LEVELS DECREASE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-NEGATIVE PATIENTS ACHIEVING A SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2AHEPATOLOGY, 2010, 52 (04) : 561A - 562ARijckborst, VincentHansen, Bettina E.Pinarbasi, BinnurAkdogan, Meralter Borg, Martijn J.Ferenci, PeterSimon, KrzysztofFlisiak, RobertAkarca, Ulus S.Raptopoulou-Gigi, MariaVerhey, Elkevan Vuuren, Anneke J.Boucher, Charles A.Janssen, Harry L.
- [6] A FINITE COURSE OF PEGINTERFERON ALFA-2A RESULTS IN INACTIVE CHRONIC HEPATITIS B AND HBSAG CLEARANCE 5 YEARS POST-TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE DISEASE: BASELINE CHARACTERISTICS AND PREDICTIVE FACTORS OF LONG-TERM RESPONSEHEPATOLOGY, 2009, 50 (04) : 487A - 487AMarcellin, PatrickPiratvisuth, TeerhaBrunetto, Maurizia R.Bonino, FerruccioFarci, PatriziaYurdaydin, CihanGurel, SelimKapprell, Hans-PeterMessinger, DiethelmBatrla, Richard
- [7] HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2BHEPATOLOGY, 2011, 54 : 1030A - 1030ASonneveld, Milan J.Rijckborst, VincentZoutendijk, RoelandGerken, GuidoTabak, FehmiMach, Tomasz H.Boucher, Charles A.Hansen, Bettina E.Janssen, Harry L.
- [8] A NOVEL COMBINATION REGIMEN OF PEGINTERFERON ALFA-2A AND ENTECAVIR RESULTS IN SUSTAINED POST-TREATMENT HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB)HEPATOLOGY, 2011, 54 : 1017A - 1017ASheng, JifangBai, XuefanWu, ShuhuanChen, JianjieSheng, JifangXie, YaoChen, ChengweiJiang, MichaelXie, Ding
- [9] HBSAG DECLINE IN HBEAG-NEGATIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2A IS ASSOCIATED WITH SUSTAINED RESPONSE UP TO 5 YEARS POST-TREATMENT: PATIENTS WITH CONTINUOUS HBSAG DECLINE STARTING BEFORE WEEK 24 ACHIEVE HIGHEST RATES OF RESPONSEHEPATOLOGY, 2009, 50 (04) : 519A - 519ABrunetto, Maurizia R.Marcellin, PatrickBonino, FerruccioKapprell, Hans-PeterMessinger, DiethelmBatrla, Richard
- [10] On-treatment HBsAg decline in HBeAg-negative patients as a predictor of response to peginterferon alfa-2a (40kd) therapy 3 years post-treatment: Potential for response-guided therapyJOURNAL OF HEPATOLOGY, 2008, 48 : S254 - S254Brunetto, M.Bonino, E.Lau, G. K. K.Farci, R.Yurdaydin, C.Piratvisuth, T.Hadziyannis, S.Lu, Z. -M.Wu, J.Popescu, M.Marcellin, P.